Cidara Therapeutics (CDTX) - Analyst Ratings

Cidara Therapeutics (CDTX) – Analyst Ratings

Jul 8, 2022 06:11 AM Needham & Company Reiterates Buy Rating, $6 Price Target on Cidara Therapeutics (CDTX)
May 12, 2022 06:21 AM Cantor Fitzgerald Reiterates Overweight Rating. $5 Price Target on Cidara Therapeutics (CDTX), "We Believe Street Under-appreciated Sales Potential of CDTX's Two Pipeline Assets"
Mar 8, 2022 06:10 AM
Mar 8, 2022 05:58 AM
Feb 17, 2022 05:55 AM
Dec 3, 2021 06:11 AM
Sep 22, 2021 04:22 AM
Mar 4, 2021 10:36 AM
Jan 29, 2021 09:46 AM
Mar 10, 2020 07:41 AM
Jan 27, 2020 01:07 PM
Dec 4, 2019 08:37 AM
Sep 4, 2019 04:22 AM
Jun 6, 2019 09:29 AM
May 17, 2019 06:28 AM
Jul 26, 2018 06:48 AM
May 23, 2018 09:30 AM
Jun 26, 2017 02:45 AM
Apr 26, 2017 10:07 AM
Apr 20, 2017 04:14 PM
Apr 17, 2017 07:23 AM
Apr 17, 2017 07:18 AM
Apr 12, 2017 09:28 AM
Apr 11, 2017 06:52 AM
Apr 10, 2017 07:22 AM
Feb 22, 2017 07:23 AM
Feb 22, 2017 07:21 AM
Feb 21, 2017 01:20 PM
Jan 4, 2017 10:45 AM
Dec 21, 2016 08:09 AM
Dec 19, 2016 07:14 AM
Oct 28, 2016 08:06 AM
Aug 16, 2016 08:21 AM
Aug 15, 2016 11:48 AM
Aug 15, 2016 08:19 AM
May 26, 2015 04:40 PM
May 11, 2015 07:25 AM
May 11, 2015 07:08 AM
May 11, 2015 06:41 AM
May 11, 2015 06:32 AM